Finance

Lists
MED:NYSE
Medifast Inc
11,67 USD
+0,43%
(+0,050) 1D
11,68 USD
+0,09% (+0,010)
Pre-market
Closed: 13-окт., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MED...
Open
11,60 USD
High
11,79 USD
Low
11,51 USD
Mkt. cap
130,48 млн
Avg. vol.
111,72 миң
Volume
184,00
52-wk high
13,58 USD
52-wk low
9,22 USD
EPS
-2,33 USD
Beta
0,68
Shares outstanding
11,18 млн
No. of employees
380
Open
11,60 USD
High
11,79 USD
Low
11,51 USD
Mkt. cap
130,48 млн
Avg. vol.
111,72 миң
Volume
184,00
52-wk high
13,58 USD
52-wk low
9,22 USD
EPS
-2,33 USD
Beta
0,68
Shares outstanding
11,18 млн
No. of employees
380
News stories
From web sources and news partners
Profile
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. Wikipedia
About Medifast Inc
CEODaniel R. Chard | Daniel R. Chard
Employees380
Founded1981
Headquarters-
SectorPersonal care products
Websitemedifastinc.com
Analyst ratings
Based on 1 analyst giving stock ratings to MED in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MED in the last 3 months
Highest
Current 11,67 USD
12,00 USD (+2,83%)
Average
12,00 USD (+2,83%)
Lowest
12,00 USD (+2,83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jim Salera
Stephens
Hold
Maintained
12,00 USD
+2,8%
08/04/2026
Last report
2026-ж., 3-авг.
Fiscal period
Q2 2026
-0,28 USD / -0,65 USD
+56,92%beat
Revenue / Est. (USD)
76,38 млн / 72,70 млн
+5,07%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
89,41 млн
75,10 млн
76,04 млн
76,38 млн
Cost of goods sold
27,25 млн
22,96 млн
24,29 млн
22,99 млн
Cost of revenue
27,25 млн
22,96 млн
24,29 млн
22,99 млн
Research and development expenses
1,10 млн
1,00 млн
1,10 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65,14 млн
58,94 млн
56,14 млн
57,72 млн
Operating expense
66,24 млн
59,94 млн
57,24 млн
57,72 млн
Total operating expenses
93,49 млн
82,90 млн
81,52 млн
80,71 млн
Operating income
-4,08 млн
-7,80 млн
-5,48 млн
-4,33 млн
Other non operating income
-2,00 миң
1,00 миң
16,00 миң
-11,00 миң
EBT including unusual items
-2,66 млн
-6,38 млн
-1,94 млн
-2,99 млн
EBT excluding unusual items
-2,66 млн
-6,38 млн
-4,08 млн
-2,99 млн
Income tax expense
-396,00 миң
11,74 млн
181,00 миң
109,00 миң
Effective tax rate
14,90%
-183,91%
-9,32%
-3,64%
Other operating expenses
-
-
-
-
Net income
-2,26 млн
-18,12 млн
-2,12 млн
-3,10 млн
Net profit margin
-2,53%
-24,13%
-2,79%
-4,06%
Earnings per share
-0,21
-1,65
-0,19
-0,28
Interest and investment income
1,43 млн
1,42 млн
1,38 млн
1,35 млн
Interest expense
-
-
-
-
Net interest expenses
1,43 млн
1,42 млн
1,38 млн
1,35 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-629,00 миң
-4,34 млн
-2,00 млн
-881,00 миң
Gain or loss from assets sale
606,00 миң
372,00 миң
-2,12 млн
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору